<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02165462</url>
  </required_header>
  <id_info>
    <org_study_id>PROPRIO-HE</org_study_id>
    <nct_id>NCT02165462</nct_id>
  </id_info>
  <brief_title>Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy</brief_title>
  <acronym>PROPRIO-HE</acronym>
  <official_title>Assessment of Bilateral Deficit Phenomenon During Dynamic Plantar Flexion Task in Patients With Haemophilic Arthropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Cat贸lica San Antonio de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Cat贸lica San Antonio de Murcia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trial to assess the bilateral deficit phenomenon during dynamic plantar flexion task in
      patients with haemophilic arthropathy Describe the differences in terms of the physical
      variables (muscular strength, range of motion and proprioception) in patients with hemophilia
      who have conducted a home treatment with a digital tool.

      Bookmark the relationship between clinical history of joint bleeds and clinical
      manifestations in standing and walking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Assess the bilateral deficit phenomenon during dynamic plantar flexion task in patients
           with haemophilic arthropathy.

        -  Indicate the independent variables that influence the development of strength and
           contractile activity, with or without previous joint bleeds in haemophilia patients with
           minors.

        -  Observe the descriptive variables people influence the standing, the incorporation from
           sitting and jumping.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Assessment of Bilateral Index of Maximal Peak Force</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of bilateral index of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Bilateral Index of Rate of Development During the Preparation Phase</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of Bilateral index of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Bilateral Index of Rate of Development During the Acceleration Phase</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of bilateral index of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Maximal Peak Force</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Rate of Development During the Preparation Phase</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Joint Condition Based on Clinical Assessment</measure>
    <time_frame>Screening visit</time_frame>
    <description>Spanish version of the Haemophilia Joint Health Score 2.1 (HJHS). Additive scale that assesses from 0 to 24 points joint status of patients with haemophilia (0: no joint damage; 24: maximum joint damage).
The variables studied in this scale are: Swelling (range 0-3); Duration of swelling (range 0-1); Muscle atrophy (range 0-2); Crepitant in motion (range 0-2); Loss of Flexion (range 0-3); Loss of extension (range 0-3); Joint pain (range 0-2): Strength (range 0-4); Gait (range 0-4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Rate of Development During the Acceleration Phase</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of Maximal Velocity of Movement</measure>
    <time_frame>Screening visit</time_frame>
    <description>Assessment of maximal velocity of movement with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight of the Patients With Haemophilia</measure>
    <time_frame>Screening visit</time_frame>
    <description>The weight were collected using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis, Severity of Hemophilia, Treatment (Prophylactic or on Demand)</measure>
    <time_frame>Screening visit</time_frame>
    <description>Patients fill out a registration key clinical data (type, severity of hemophilia, hemarthrosis in the previous month and current drug therapy).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint Bleeding Before the Assessment</measure>
    <time_frame>Screening visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height of the Patients With Haemophilia</measure>
    <time_frame>Screening visit</time_frame>
    <description>The height of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index of Patients With Haemophilia</measure>
    <time_frame>Screening visit</time_frame>
    <description>The body mass index of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age of Patients With Haemophilia</measure>
    <time_frame>Screening visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Hemophilia</condition>
  <arm_group>
    <arm_group_label>Patients with haemophilia</arm_group_label>
    <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patients with haemophilia</intervention_name>
    <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
    <arm_group_label>Patients with haemophilia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with haemophilia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with hemophilia A and B.

          -  With or without joint involvement clinically diagnosed, and with or without a previous
             history of hemarthrosis joint load legs.

          -  In prophylactic regimen with FVIII / FIX concentrates .

          -  Residents in the Autonomous Community of the Region of Murcia.

        Exclusion Criteria:

          -  Patients without walking ability.

          -  Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).

          -  Patients with neurological or cognitive impairments that prevent understanding the
             questionnaires and physical tests.

          -  Patients whose parents or guardians have not signed the informed consent document.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JUAN JOSE RODRIGUEZ, MsC</last_name>
    <role>Study Chair</role>
    <affiliation>Universidad Cat贸lica San Antonio</affiliation>
  </overall_official>
  <overall_official>
    <last_name>RUBEN CUESTA-BARRIUSO, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Cat贸lica San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Cat贸lica San Antonio, Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30107</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2014</study_first_submitted>
  <study_first_submitted_qc>June 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2014</study_first_posted>
  <results_first_submitted>October 7, 2015</results_first_submitted>
  <results_first_submitted_qc>November 11, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 15, 2015</results_first_posted>
  <last_update_submitted>June 29, 2016</last_update_submitted>
  <last_update_submitted_qc>June 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Cat贸lica San Antonio de Murcia</investigator_affiliation>
    <investigator_full_name>Rub茅n Cuesta-Barriuso, PhD</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Haemophilia</keyword>
  <keyword>Arthropathy</keyword>
  <keyword>Bilateral deficit phenomenon</keyword>
  <keyword>Proprioception</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients with haemophilia</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients With Haemophilia</title>
          <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients With Haemophilia</title>
          <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.47" spread="7.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Bilateral Index of Maximal Peak Force</title>
        <description>Assessment of bilateral index of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA).</description>
        <time_frame>Screening visit</time_frame>
        <population>Bilateral rates was calculated during the preparation phase and during the acceleration phase to express relative difference in strength between bilateral and unilateral conditions. Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Bilateral Index of Maximal Peak Force</title>
          <description>Assessment of bilateral index of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA).</description>
          <population>Bilateral rates was calculated during the preparation phase and during the acceleration phase to express relative difference in strength between bilateral and unilateral conditions. Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-40.86" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Bilateral Index of Rate of Development During the Preparation Phase</title>
        <description>Assessment of Bilateral index of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <population>Bilateral rates was calculated during the preparation phase to express relative difference in strength between bilateral and unilateral conditions (calculated in percentages). Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Bilateral Index of Rate of Development During the Preparation Phase</title>
          <description>Assessment of Bilateral index of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <population>Bilateral rates was calculated during the preparation phase to express relative difference in strength between bilateral and unilateral conditions (calculated in percentages). Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.34" spread="56.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Bilateral Index of Rate of Development During the Acceleration Phase</title>
        <description>Assessment of bilateral index of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <population>Bilateral rates was calculated during the acceleration phase to express relative difference in strength between bilateral and unilateral conditions (calculated in percentages). Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Bilateral Index of Rate of Development During the Acceleration Phase</title>
          <description>Assessment of bilateral index of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <population>Bilateral rates was calculated during the acceleration phase to express relative difference in strength between bilateral and unilateral conditions (calculated in percentages). Based on information in the Howard and Enoka (1991), the calculation detail for the Bilateral Index is &quot;[100x (bilateral) / (right unilateral + left unilateral)] - 100&quot;</population>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.05" spread="38.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Maximal Peak Force</title>
        <description>Assessment of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <population>The maximum peak force (MPF) is defined as the maximum achieved in the force-time curve during the dynamic test plantar flexion for both bilateral conditions as right and left unilateral, normalized to body weight of the participants (N / kg value)</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Maximal Peak Force</title>
          <description>Assessment of maximal peak force with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <population>The maximum peak force (MPF) is defined as the maximum achieved in the force-time curve during the dynamic test plantar flexion for both bilateral conditions as right and left unilateral, normalized to body weight of the participants (N / kg value)</population>
          <units>N/kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.67" spread="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Rate of Development During the Preparation Phase</title>
        <description>Assessment of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Rate of Development During the Preparation Phase</title>
          <description>Assessment of rate of development during the preparation phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <units>N/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6190.86" spread="2818.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change of Joint Condition Based on Clinical Assessment</title>
        <description>Spanish version of the Haemophilia Joint Health Score 2.1 (HJHS). Additive scale that assesses from 0 to 24 points joint status of patients with haemophilia (0: no joint damage; 24: maximum joint damage).
The variables studied in this scale are: Swelling (range 0-3); Duration of swelling (range 0-1); Muscle atrophy (range 0-2); Crepitant in motion (range 0-2); Loss of Flexion (range 0-3); Loss of extension (range 0-3); Joint pain (range 0-2): Strength (range 0-4); Gait (range 0-4)</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Change of Joint Condition Based on Clinical Assessment</title>
          <description>Spanish version of the Haemophilia Joint Health Score 2.1 (HJHS). Additive scale that assesses from 0 to 24 points joint status of patients with haemophilia (0: no joint damage; 24: maximum joint damage).
The variables studied in this scale are: Swelling (range 0-3); Duration of swelling (range 0-1); Muscle atrophy (range 0-2); Crepitant in motion (range 0-2); Loss of Flexion (range 0-3); Loss of extension (range 0-3); Joint pain (range 0-2): Strength (range 0-4); Gait (range 0-4)</description>
          <units>Units on a scale (range 0-24)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right knee</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.88" spread="4.076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left knee</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" spread="2.398"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right ankle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.82" spread="3.575"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left ankle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.35" spread="4.527"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Rate of Development During the Acceleration Phase</title>
        <description>Assessment of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Rate of Development During the Acceleration Phase</title>
          <description>Assessment of rate of development during the acceleration phase with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <units>N/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8945.25" spread="2807.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Maximal Velocity of Movement</title>
        <description>Assessment of maximal velocity of movement with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        <time_frame>Screening visit</time_frame>
        <population>The maximum speed (Vmax) was calculated as the maximum value of the first integral of the force-time curve for bilateral contractions, left-sided and right-sided</population>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Maximal Velocity of Movement</title>
          <description>Assessment of maximal velocity of movement with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          <population>The maximum speed (Vmax) was calculated as the maximum value of the first integral of the force-time curve for bilateral contractions, left-sided and right-sided</population>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight of the Patients With Haemophilia</title>
        <description>The weight were collected using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA)</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Weight of the Patients With Haemophilia</title>
          <description>The weight were collected using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA)</description>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.48" spread="15.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis, Severity of Hemophilia, Treatment (Prophylactic or on Demand)</title>
        <description>Patients fill out a registration key clinical data (type, severity of hemophilia, hemarthrosis in the previous month and current drug therapy).</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis, Severity of Hemophilia, Treatment (Prophylactic or on Demand)</title>
          <description>Patients fill out a registration key clinical data (type, severity of hemophilia, hemarthrosis in the previous month and current drug therapy).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Haemophilia A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Haemophilia B</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Severe haemophilia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate haemophilia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mild haemophilia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prophylaxis treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>On demand treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Joint Bleeding Before the Assessment</title>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Joint Bleeding Before the Assessment</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Height of the Patients With Haemophilia</title>
        <description>The height of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Height of the Patients With Haemophilia</title>
          <description>The height of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176.53" spread="6.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index of Patients With Haemophilia</title>
        <description>The body mass index of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index of Patients With Haemophilia</title>
          <description>The body mass index of patients was calculated using a TANITA equipment (TBF-300WA model, Tanita Corporation of America, Inc., Illinois, USA).</description>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.36" spread="4.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Age of Patients With Haemophilia</title>
        <time_frame>Screening visit</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With Haemophilia</title>
            <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
          </group>
        </group_list>
        <measure>
          <title>Age of Patients With Haemophilia</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.47" spread="7.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse Events were not collected/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Patients With Haemophilia</title>
          <description>Assessment of bilateral deficit phenomenon during dynamic plantar flexion task
Patients with haemophilia: Assessment of bilateral deficit phenomenon during dynamic plantar flexion task with a force platform (Kistler 9286 BA model, Kistler Instruments, Amherst, NY, USA)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rub茅n Cuesta-Barriuso, PhD</name_or_title>
      <organization>Universidad Cat贸lica San Antonio de Murcia</organization>
      <phone>+34 913146508</phone>
      <email>ruben.cuestab@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

